Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment
Authors:
Open Access
- 20 April 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Abstract
To investigate the association between serum neurofilament light chain (NfL) levels, inflammatory cytokines, and cognitive function to assess their utility in the early detection of mild cognitive impairment (MCI). We conducted a cross-sectional study involving 157 community-dwelling individuals aged 55 years and above, categorized into healthy controls, MCI, and probable Alzheimer's disease (AD). Serum levels of NfL, inflammatory cytokines, and AD pathology markers were measured using enzyme-linked immunosorbent assay (ELISA). Correlations between these biomarkers and cognitive function were analyzed, and the diagnostic performance of the cognitive assessment scales and serum biomarker concentrations was evaluated using receiver operating characteristic (ROC) curve analysis. Serum NfL levels were significantly elevated in MCI and probable AD groups compared to healthy controls. Positive correlations were found between serum NfL and inflammatory cytokines IL-1β, IL-6, and Aβ40. Combining serum NfL with p-tau217 and the Boston Naming Test significantly enhanced the predictive accuracy for MCI. However, combining serum NfL with inflammatory markers did not improve MCI prediction accuracy. Elevated serum NfL is associated with cognitive impairment and inflammatory markers, suggesting its potential as a peripheral serum biomarker for MCI detection. The combination of serum NfL with p-tau217 and cognitive tests could offer a more accurate prediction of MCI, providing new insights for AD treatment strategies.Keywords
All Related Versions
Funding Information
- The government funded clinical medicine excellent talents training project of Hebei Province (ZF2024136)
- the Special Fund Project of the Central Government to Guide the Local Science and Technology Development of Hebei Province (199477138G)
- Science and Technology Program of Hebei Province (SG2021189)
This publication has 41 references indexed in Scilit:
- Alzheimer's disease as an innate autoimmune disease (AD2): A new molecular paradigmAlzheimer's & Dementia, 2022
- Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive ImpairmentJournal of Neurology, 2022
- Aging and sex impact plasma NFL and t‐Tau trajectories in individuals at risk for Alzheimer’s diseaseAlzheimer's & Dementia, 2020
- Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s diseaseAnnals of Clinical and Translational Neurology, 2020
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology, 2019
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology, 2017
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease ProgressionJAMA Neurology, 2016
- Systemic inflammation induces axon injury during brain inflammationAnnals of Neurology, 2011
- Neuroinflammatory processes in Alzheimer’s diseaseJournal of Neural Transmission, 2010
- Peripheral inflammatory biomarkers of Alzheimer’s disease: the role of plateletsBiogerontology, 2010